Gaudium IVF intimated BSE and NSE of its board meeting on May 28, 2026 to approve audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
The company will submit the results along with the statutory auditor's report to the exchanges in compliance with SEBI Listing Regulations.
The trading window for designated persons remains closed since April 1, 2026 and will reopen 48 hours after results declaration.